Position in JAZZ
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$768,694
New position
Shares Held
3,190
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 69 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 98.4639498432602.ToString("F0")%
Shared 0.ToString("F0")%
None 1.536050156739812.ToString("F0")%
Position in Biotechnology
Healthcare · as of Jun 30, 2026DAVENPORT & Co LLC holds $137,698,050 across 19 Biotechnology names. JAZZ ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,108 | $102,876,756 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
283,960 | $22,515,188 | |
| 3 | CGTX |
Cognition Therapeutics Inc
|
4,259,511 | $4,898,437 | |
| 4 | GMAB |
Genmab A/S
|
42,544 | $1,168,683 | |
| 5 | MGTX |
MeiraGTx Holdings plc
|
72,370 | $977,718 | |
| 6 | ARGX |
Argenx SE
|
929 | $861,898 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
3,190 | $768,694 | |
| 8 | RARE |
Ultragenyx Pharmaceutical Inc.
|
19,500 | $651,105 |
All Filings in JAZZ
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $768,694 | 3,190 | Shares | Sole | 2026-07-13 | |
| No filing history on record for this holder in this stock. | ||||||